Rxo (RXO) Non-Current Deferred Tax Liability (2021 - 2025)
Rxo (RXO) has disclosed Non-Current Deferred Tax Liability for 5 consecutive years, with $54.0 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Non-Current Deferred Tax Liability fell 53.04% year-over-year to $54.0 million, compared with a TTM value of $54.0 million through Sep 2025, down 53.04%, and an annual FY2024 reading of $88.0 million, up 1157.14% over the prior year.
- Non-Current Deferred Tax Liability was $54.0 million for Q3 2025 at Rxo, down from $75.0 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $115.0 million in Q3 2024 and bottomed at $1.0 million in Q1 2024.
- Average Non-Current Deferred Tax Liability over 5 years is $44.4 million, with a median of $44.0 million recorded in 2022.
- The sharpest move saw Non-Current Deferred Tax Liability plummeted 93.75% in 2024, then skyrocketed 7600.0% in 2025.
- Year by year, Non-Current Deferred Tax Liability stood at $52.0 million in 2021, then crashed by 69.23% to $16.0 million in 2022, then crashed by 56.25% to $7.0 million in 2023, then skyrocketed by 1157.14% to $88.0 million in 2024, then tumbled by 38.64% to $54.0 million in 2025.
- Business Quant data shows Non-Current Deferred Tax Liability for RXO at $54.0 million in Q3 2025, $75.0 million in Q2 2025, and $77.0 million in Q1 2025.